Clinical Trials List
Protocol NumberBJT-778-304
Active
2026-01-13 - 2028-07-24
Phase III
Not yet recruiting1
Recruiting2
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Lung Yu 無
- Chung-Feng Huang 無
- 梁博程 無
- Ming-Lun Yeh 無
- Chia-Yen Dai 無
- 王志文 無
- Jee-Fu Huang 無
- 魏鈺儒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
120 participants
